Study: Fish Oil Doesn ’ t Seem To Prevent Heart Problems

This study is consistent with earlier trials. The US Food and Drug Administration approved the fish oil-based drug Vascepa for heart attack and stroke prevention in 2019. Nissen hopes the FDA will take a look at these studies and reconsider that decision. “But it’s hard to get something undone once the genie gets out of the bottle,” he said. An editorial in the journal that accompanies the study written by Dr. Gregory Curfman, assistant professor of medicine at Harvard Medical School, also suggested the FDA should require a postmarketing clinical trial of a high-dose of fish oil, such as Vascepa, vs. corn oil in patients at risk for cardiovascular events, to “shed further light on this perplexing clinical issue and research question.” The-CNN-Wire & © 2020 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston CNN fish oil Source Type: news